Expert discusses how, despite its importance, albuminuria screening remains underutilized, and improving adherence to dual ...

Elevidys now carries a black box warning for acute liver injury and failure, limiting its use to ambulatory patients aged four and older. The FDA's actions follow fatal liver failure reports in ...

Sandoz’s Tyruko (natalizumab), the only FDA approved natalizumab biosimilar for adults with relapsing multiple sclerosis and Crohn’s disease, is now available by prescription in the United States ...

The results speak plainly. Spain spends 9.2 percent of GDP on health care; we spend 17.2 percent. Spaniards live to an ...

Here’s what you missed this week on Managed Healthcare Executive. Each Sunday we feature a highlight reel of various articles posted on our website that week. We’ll be back on Monday morning with more ...

Keytruda showed a significant survival benefit over Tecentriq and Opdivo in older adults with metastatic NSCLC, with a 33% ...

Newly analyzed data from Japan adds to the evidence that COVID-19 may increase the risk of shingles.

Veterans who enter the healthcare workforce have a 29% higher chance at promotion and have a 14% higher retention rate than ...

Menopause care is not one-size-fits-all, especially for gender nonconforming individuals, including transgender, nonbinary ...

Managed Healthcare Executive interviewed OneHome’s Noel Gilliam, Vice President of Value-Based Product Design, to discuss the ...

mRNA vaccines can enhance immunotherapy efficacy by activating the immune system, improving outcomes in hard-to-treat tumors. mRNA COVID-19 vaccines enhance immune responses, improving cancer ...

Poherdy is the first FDA-approved interchangeable biosimilar to Perjeta for HER2-positive breast cancer, potentially expanding access and reducing costs. Approved for use in combination with ...